Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiri Vencovsky

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Arthritis Research & Therapy|September 6, 2017
Opportunities and challenges in rheumatology research in Central EuropeZoltán Szekanecz, Branimir Anic, Gábor Héjj, et al.
Rheumatology (Oxford, England)|August 2, 2015
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early diseaseMichal Tomcik, Pawel Zerr, Katrin Palumbo-Zerr, et al.
Scandinavian Journal of Immunology|November 20, 2018
Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositisQuan Tang, Daniel Ramsköld, Olga Krystufkova, et al.
The Journal of Rheumatology|August 17, 2019
Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I)Marie Skougaard, Henning Bliddal, Robin Christensen, et al.
Biomarkers in Medicine|January 11, 2021
Plasma heat shock protein 90 levels in patients with spondyloarthritis and their relation to structural changes: a cross-sectional studyKristyna Bubova, Hana Storkanova, Sabina Oreska, et al.
Annals of the Rheumatic Diseases|October 11, 2017
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trialAnna Tjärnlund, Quan Tang, Cecilia Wick, et al.
Frontiers in Medicine|May 23, 2022
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional StudySabina Oreska, Hana Storkanova, Jaroslav Kudlicka, et al.
Rheumatology (Oxford, England)|October 17, 2022
Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational studyNadège Cordel, Benoît Dechelotte, Fabienne Jouen, et al.
Seminars in Arthritis and Rheumatism|January 19, 2024
Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - A longitudinal studyKarin Lodin, Fabricio Espinosa-Ortega, Maryam Dastmalchi, et al.
Rheumatology (Oxford, England)|June 6, 2023
Cardiovascular risk in myositis patients compared with the general populationSabina Oreska, Hana Storkanova, Aneta Pekacova, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Arthritis Research & Therapy|September 6, 2017
Opportunities and challenges in rheumatology research in Central EuropeZoltán Szekanecz, Branimir Anic, Gábor Héjj, et al.
Rheumatology (Oxford, England)|August 2, 2015
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early diseaseMichal Tomcik, Pawel Zerr, Katrin Palumbo-Zerr, et al.
Scandinavian Journal of Immunology|November 20, 2018
Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositisQuan Tang, Daniel Ramsköld, Olga Krystufkova, et al.
The Journal of Rheumatology|August 17, 2019
Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I)Marie Skougaard, Henning Bliddal, Robin Christensen, et al.
Biomarkers in Medicine|January 11, 2021
Plasma heat shock protein 90 levels in patients with spondyloarthritis and their relation to structural changes: a cross-sectional studyKristyna Bubova, Hana Storkanova, Sabina Oreska, et al.
Annals of the Rheumatic Diseases|October 11, 2017
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trialAnna Tjärnlund, Quan Tang, Cecilia Wick, et al.
Frontiers in Medicine|May 23, 2022
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional StudySabina Oreska, Hana Storkanova, Jaroslav Kudlicka, et al.
Rheumatology (Oxford, England)|October 17, 2022
Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational studyNadège Cordel, Benoît Dechelotte, Fabienne Jouen, et al.
Seminars in Arthritis and Rheumatism|January 19, 2024
Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - A longitudinal studyKarin Lodin, Fabricio Espinosa-Ortega, Maryam Dastmalchi, et al.
Rheumatology (Oxford, England)|June 6, 2023
Cardiovascular risk in myositis patients compared with the general populationSabina Oreska, Hana Storkanova, Aneta Pekacova, et al.
Pageof 7